Wave Life Sciences
Yahoo Finance • 6 days ago
Oppenheimer and Truist Lift Wave Life Sciences Ltd. (WVE) Price Targets After Positive Trial
We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. Wave Life Sciences Ltd. tops our list for being one of the most promising stocks. TheFly reported on December 16 that Oppenheimer raised its pr... Full story
Yahoo Finance • 15 days ago
Wave Life (WVE) Shares Nearly Triple on Encouraging Obesity Drug Trial
We recently published 10 Stocks Delivering Explosive 18-190% Gains. Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the last week’s heavy gainers. Wave Life Sciences nearly tripled its share price on a week-on-week basis, as investors posi... Full story
Yahoo Finance • 18 days ago
Eli Lilly Puts Obesity Field 'On Notice' With Best-Ever Weight Loss
Eli Lilly is putting the "obesity field on notice again," an analyst said Thursday after its next-gen delivered 28.7% weight loss. Continue Reading... Full story
Yahoo Finance • 18 days ago
Eli Lilly's Experimental Obesity Drug Cut Weight By 23.7%
Eli Lily rose above a key level after saying its experimental obesity treatment delivered 23.7% weight loss in a late-stage trial. Continue Reading... Full story
Yahoo Finance • 19 days ago
Wave Life Science prices upsized $350M stock ofeering
* Wave Life Sciences (WVE [https://seekingalpha.com/symbol/WVE]) priced [https://seekingalpha.com/pr/20334510-wave-life-sciences-prices-upsized-350-million-public-offering-of-ordinary-shares-and-pre] an upsized underwritten public offeri... Full story
Yahoo Finance • 19 days ago
Wave Life Sciences Prices Upsized $350 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
CAMBRIDGE, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health (“Wave” or “Wave Life S... Full story
Yahoo Finance • 20 days ago
Trending tickers: Nvidia, Wave Life, Toll Brothers, British American Tobacco and Moonpig
Nvidia (NVDA) US president Donald Trump announced on Monday that he will allow the sale of Nvidia's (NVDA) more powerful H200 chips to China. Trump wrote in a post on Truth Social on Monday that he had informed China's president Xi Jinpi... Full story
Yahoo Finance • 20 days ago
After-Hours Gainers: Exicure Tops List With 72% Jump, Wave Life And Assembly Biosciences Advance
(RTTNews) - Biotechnology stocks saw notable movement in after-hours trading on Monday, with several companies posting strong gains. Below is a structured look at the key movers and the developments driving their performance. Exicure, Inc... Full story
Yahoo Finance • 21 days ago
Biggest Stock Movers Today, Dec. 8: CFLT, UL, & More
Key Points Major stock market indexes were mixed on Thursday. Some AI stocks rose while others fell as earnings results kept coming out.10 stocks we like better than Confluent › Investors came into the new week on Monday largely in wait-... Full story
Yahoo Finance • 21 days ago
Wave Life Sciences Announces Proposed $250 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
CAMBRIDGE, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health (“Wave” or “Wave Life S... Full story
Yahoo Finance • 21 days ago
BC-Most Active Stocks
NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Paranovus Entertain.Tech. Ltd. 852,838,067 0.0658 0.0476 0.05 +0.0134 Co... Full story
Yahoo Finance • 21 days ago
Turnarounds and 18,000% Growth
DENVER, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Markets opened the week with a burst of small-cap energy as several niche innovators, spanning luxury foods, next-gen biomaterials, and RNA therapeutics, delivered updates that injected fresh opt... Full story
Yahoo Finance • 21 days ago
Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss
Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared to baseline, with a 9.4% reduction in visceral fat (p=0.02), a 4.5% reduction in total body fat (3.5 lbs; p=0.07),... Full story
Yahoo Finance • 22 days ago
Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025
CAMBRIDGE, Mass., Dec. 07, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will announce interim... Full story
Yahoo Finance • 2 months ago
After-Hours Gainers: MGNX, SLS, KRMD, HYPR, WVE Post Sharp Moves Following Q3 Updates
(RTTNews) - Several small-cap healthcare and biotech names posted notable price increases in after-hours trading on Wednesday, following earnings updates or ahead of scheduled financial disclosures. MacroGenics, Inc. (MGNX) rose 10.2% to... Full story
Yahoo Finance • 2 months ago
Wave Life Sciences signals INLIGHT trial data for over 100 participants by H1 2026 while advancing RNA editing pipeline
Earnings Call Insights: Wave Life Sciences Ltd. (WVE) Q3 2025 MANAGEMENT VIEW * Paul Bolno, President, CEO & Director, highlighted the company's "first ever demonstration of activin E reductions in a clinical trial" with WVE-007, repor... Full story
Yahoo Finance • 2 months ago
Wave Life Sciences Reports Third Quarter 2025 Financial Results and Provides Business Update
WVE-007, an INHBE GalNAc-siRNA for obesity designed to drive fat loss while preserving muscle mass, achieved dose-dependent, mean reductions of Activin E of up to 85% in INLIGHT clinical trial, exceeding levels that led to weight loss and... Full story
Yahoo Finance • 2 months ago
Wave Life Sciences Q3 2025 Earnings Preview
* Wave Life Sciences (WVE [https://seekingalpha.com/symbol/WVE]) is scheduled to announce Q3 earnings results on Monday, November 10th, before market open. The consensus EPS Estimate is -$0.30 [https://seekingalpha.com/symbol/WVE/earning... Full story
Yahoo Finance • 2 months ago
Wave Life Sciences to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that m... Full story
Yahoo Finance • 2 months ago
Wave Life Sciences to Present Preclinical Data Supporting Therapeutic Potential of WVE-007 for Obesity at ObesityWeek® 2025
Presentation will highlight preclinical data supporting the potential of WVE-007 (INHBE GalNAc-siRNA) as a unique approach for the treatment of obesity designed to drive fat loss while preserving muscle mass with once or twice annual dosin... Full story
